Propofol , wanda aka sayar a ƙarƙashin sunan suna Diprivan, ya ƙunshi duka lecithin kwai da waken soya . Saboda haka, likitoci da dama sun damu cewa bazai iya zama lafiya ga mutanen da ke dauke da ciwon sukari ga irin abincin ba, musamman ma rashin lafiyar dabbobi.
Nazarin ya nuna cewa propofol ya bayyana ya kasance lafiya a mafi yawan mutanen da ke rashin lafiyar ƙwayoyin. Duk da haka, akwai rahotanni na harkar rashin lafiyar da suka faru bayan sunyi amfani da miyagun ƙwayoyi a cikin mutanen da ke dauke da kwayar cutar ta anaphylactic .
Propofol yana amfani da cutar
Propofol wani abu ne mai karfi wanda ke sa ka kwantar da hankali da barcinka ta hanyar rage jinkirin aikin kwakwalwarka da kuma juyayi. An ba ta ta hanyar allura a cikin jikinka, kuma da zarar ka karbi shi, tabbas ba za ka tuna da kome ba - za ka fara barci sosai da sauri.
Ana amfani da miyagun ƙwayoyi a cikin raƙuman kulawa mai kulawa don satar mutanen da ke cikin masu kwantar da hankali, kuma a cikin dakunan gaggawa kamar maganin rigakafi don hanyoyi kaɗan da mai zafi. Ba'a amfani dashi a waje da wani asibiti, saboda yana da matukar hatsari ba tare da saka idanu da horo ba. A gaskiya ma, propofol ne miyagun ƙwayoyi da suka kashe mawaki Michael Jackson.
Propofol ya zama daya daga cikin maganin likitanci da aka fi so don amfani, duka a wurare inda mai haƙuri kawai yake buƙatar barci don 'yan mintoci kaɗan (alal misali, a yi aiki mai raɗaɗi, kamar sake saɓin ƙafar da aka yanke) da kuma a lokuta da ya fi tsayi Ana buƙata.
Ba ya buƙatar saka hankali sosai saboda yana iya sa ka dakatar da numfashi.
Propofol da Shirye-ƙari
Kamar yadda aka fada a sama, propofol ya haɗa da lacithin kwai a cikin wannan tsari. Lecithin wani nau'i ne na mai, ba gina jiki ba, kuma yawancin abincin da ke tattare da kwai ya ƙunshi furotin, ba fat din a cikin qwai ba.
Duk da haka, maganin miyagun ƙwayoyi na propofol ya nuna cewa mutane da ciwon sukari ga duk wani magungunan miyagun ƙwayoyi bazai yi amfani da maganin ba, kuma akwai lokutta da dama da ke nuna rashin lafiyan halayen da zai iya kasancewa ga propofol.
Da aka ce, likitoci sun dubi yin amfani da propofol a cikin mutanen da ke rashin lafiyar ƙwai kuma sun samo shi a kullum yana nuna lafiya.
Ɗaya daga cikin nazarin binciken Australiya ya yi nazari game da lokuta na yara 28 da ciwon kwari, waɗanda suke da kamfani na 43 da suke amfani da su a tsakanin su. Biyu daga cikin yara suna da tarihi na halayen anaphylactic to qwai. Akwai wani rashin lafiyar cutar rashin anaphylactic a cikin wani ɗa mai shekaru bakwai da yake rashin lafiyar ƙwai, da madara , kwayoyi, da kuma sesame . Hakan ya faru a minti 15 bayan amfani da propofol, kuma yaron ya amsa zuwa gwajin fata tare da propofol. Mawallafa sun yanke shawarar cewa mai yiwuwa propofol zai kasance lafiya cikin mafi yawan mutanen da ke da kwayar cutar.
Wani binciken kuma ya duba lokuta idan manya da gwagwarmaya masu fata sun fara yin amfani da kwayoyi, ƙyan zuma ko kirkiro sunyi amfani da su. Ba ta sami wata dangantaka tsakanin rashin lafiyar halayen da kuma propofol ba.
Layin Ƙasa
Bisa ga waɗannan bincike na bincike, propofol ya kasance lafiya cikin yawancin mutanen da ke dauke da ƙwayar nama. Duk da haka, ya kamata ka yi magana da likitanka game da shi idan kana da rashin lafiyar ƙwai, musamman ma idan kana da halayen anaphylactic zuwa qwai a baya. Dangane da rashin lafiyar ƙwayar jikinka, likitanku na iya bada shawara ga wani magani na rigakafi.
Sources:
Asserhøj LL et al. Babu shaida don ƙin yarda da amfani da propofol a cikin matasan da ke rashin lafiyar kwai, soya ko kirki. Jaridar British Journal of Anesthesia. 2016 Jan; 116 (1): 77-82.
Diprivan 1%. Diprivan Monograph bayar da mai yin magunguna AstraZeneca. Agusta, 2005.
Hepner, DL, MD da MC Castells, PhD. Anaphylaxis A lokacin Zaman Lafiya. Anesthesia da Analgesia. Nov 2003. Vol. 97 A'a. 5.
Hofer K et al. Anaphylaxis mai yiwuwa yiwu bayan propofol a cikin yaro da rashin lafiyar abinci. Annals na Pharmacotherapy. 37 (3): 398-401, 2003.
Murphy A et al. Rashin haɗarin rashin tausayi don haifar da kananan yara. Anesthesia & Analgesia. 2011 Jul; 113 (1): 140-4.